Does larotrectinib need to be combined with other medications?

Larotrectinib is often used as monotherapy, particularly for patients with cancers that harbor NTRK gene fusions. This is because larotrectinib is a highly targeted drug specifically designed to inhibit the activity of NTRK fusion proteins, thereby preventing the growth and spread of tumor cells. For these patients, larotrectinib is often an effective treatment option without the need for combination with other anticancer drugs.

However, sometimes doctors may consider combining different types of medications, especially if:

1.Resistance to anticancer treatments: Sometimes, tumor cells may develop resistance to larotrectinib or other targeted drugs. In this case, doctors may consider combining larotrectinib with other anticancer drugs to make the treatment more effective.

2.Need for multidrug therapy: Certain cancer types may require a combination of treatment strategies, including surgery, radiation therapy, and medications. Larotrectinib can be used as a component of this, but may need to be used with other treatments for optimal results.

3.Pre- or post-treatment strategies: In some cases, larotrectinib may be used in combination with other treatments as a prelude to treatment or as part of subsequent treatment.

Larotrectinib has been launched in China, but it has not been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.